六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioScience(AYTU)$ 425 Prospectuses and communications, business combinations Accession Number: 0001654954-19-013813 Act: 34 Size: 1 MB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001654954-19-013811 Act: 34 Size: 1 MB 网页链接
$Aytu BioScience(AYTU)$ 425 Prospectuses and communications, business combinations Accession Number: 0001654954-19-013534 Act: 34 Size: 3 MB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001654954-19-013481 Act: 34 Size: 97 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, item 8.01 Accession Number: 0001654954-19-013400 Act: 34 Size: 27 KB 网页链接
$Aytu BioScience(AYTU)$ PRER14A Preliminary Proxy Soliciting materials Accession Number: 0001654954-19-013291 Act: 34 Size: 664 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001654954-19-013023 Act: 34 Size: 351 KB 网页链接
$Aytu BioScience(AYTU)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001654954-19-013026 Act: 34 Size: 3 MB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 3.01 and 8.01 Accession Number: 0001654954-19-012593 Act: 34 Size: 48 KB 网页链接
$Aytu BioScience(AYTU)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-11-07 AccNo: 0000919574-19-006765 Size: 91 KB 网页链接